ǰÑÔ
Ó¦ÓûùÒò¹¤³ÌµÈʵÑéÊÖÒÕ¶Ô¶¯Îï»ùÒò×é¾ÙÐÐÓÐÄ¿µÄµÄÒÅ´«ÐÞÊΣ¬ÕâÖÖ±»ÐÞÊÎˢеĻùÒò¿ÉÎȹÌÒÅ´«¸ø×ÓÅ®¶¯Îï¡£»ùÒòÇóýºÍת»ùÒòÊÇ»ùÒòÐÞÊÎÅÁ½ðɲ¡¶¯ÎïÄ£×ÓµÄÖ÷ÒªÖÆ×÷ÒªÁì¡£
²¿·ÖÔìÄ£ÒªÁì
ʹÓö¯Î´óÊó
¡¾ÔìÄ£»úÖÆ¡¿£º
1. DJ-1ÊÇÒ»ÖÖÖ÷ÒªµÄÅÁ½ðɲ¡Ïà¹ØÖ²¡»ùÒò£¬DJ-1»ùÒòÇóýСÊó»òDJ-1±í´ïϵ÷µÄDAÄÜϸ°û¶ÔÑõ»¯Ó¦¼¤µÄÃô¸ÐÐÔÔöÌí£¬Ï¸°û¿¹Ñõ»¯Ó¦¼¤ÄÜÁ¦½µµÍ¼°ÏìÓ¦ÐźÅͨ·±¬·¢¸Ä±ä£¬ÖÂʹÉñ¾ÔªµòÍö¼ÓËÙ£¬´Ó¶ø¿ÉÄÜÖÆ×÷³öÅÁ½ðɲ¡»ùÒòÐÞÊζ¯ÎïÄ£×Ó¡£
2. ÔºËÏÔ΢עÉä·¨ÊÇÏÖÔÚÖÆ×÷ת»ùÒò¶¯Îï×î³£ÓõÄÒªÁì¡£½«¹¹½¨ºÃµÄa-synuclein»ùÒòÖ±½Ó×¢Éäµ½Êܾ«ÂѵÄÐÛÔºËÖУ¬È»ºó½«Ð¯´øÍâÔ´»ùÒòµÄÊܾ«ÂÑÒÆÖ²µ½Í¬Æ·Ïµ¼ÙÔÐÊÜÌåµÄÊäÂѹÜÖУ¬¿É»ña-synucleinת»ùÒòСÊ󣬷¢Ã÷¸ÃСÊóLewyСÌåÐγɼÓËÙ¡¢Éñ¾ÔªµòÍöÔöÌí¡£
¡¾Ä£×ÓÌØµã¡¿£º
×÷ΪÒÅ´«Ò׸ÐÐÔÊܵ½¶à»ùÒòÁªÏàÖúÓõļ²²¡£¬Èκμòµ¥»ùÒòÐÞÊÎÒòËØÔÚÅÁ½ðɲ¡Ö²¡Öж¼»áÓÐÒ»¶¨×÷Ó㬵«¶¼²»ÆðÖ÷Òª×÷Óûò¾öÒéÐÔ×÷Óá£Òò´Ë£¬Í¨¹ýÏÖÓеĻùÒòÐÞÊÎ֪ʶºÍÊÖÒÕ£¬ÖÆ×÷µÄÅÁ½ðɲ¡¶¯ÎïÄ£×Ó¶¼ÓÐȱÏÝ£¬ÌåÏÖ³ö¼òµ¥µÄÉñ¾»¯Ñ§ÔÓÂÒÄ£ËÆÐÔ»òÉñ¾²¡Àíת±äÄ£ËÆÐÔ£¬Æä±íÐÍÌØµã£¨ÌØÊâÊÇÏ¸Î¢ÌØÕ÷£©ÓëÅÁ½ðɲ¡»¼Õß¶¼Óнϴó²î±ð¡£
¡¾Ä£×ӵįÀ¹ÀºÍÓ¦Óá¿£º
̽Ë÷ÖеÄÅÁ½ðɲ¡»ùÒòÐÞÊζ¯ÎïÄ£×ÓÒ»¶¨ÓÐÆäÁÉÀ«µÄÓ¦ÓÃÔ¶¾°£¬µ«Í¬Ê±ÉдæÐí¶àÎÊÌâÓдýսʤ¡£Òò´Ë£¬Ïֽ׶λùÒòÐÞÊζ¯ÎïÄ£×ÓµÄÓ¦Ó㬻¹ÔÝʱֻͣÁôÔÚÖ²¡»úÖÆÑо¿¡¢Éñ¾Ôª±£»¤²½·¥É¸Ñ¡µÈÑо¿ÉÏ¡£
²Î¿¼ÎÄÏ×£º
1.³ÂÉúµÜ£®ÅÁ½ðɲ¡£®±±¾©£ºÈËÃñÎÀÉú³öÊéÉ磬2006
2.Engeln M, Ahmed SH, Vouillac C, el al. Reinforcing properties of Praroipexole in normal and parkinsooian rats.Neurobiol Dis, 2012, 49C: 79-86
3.Hoehn MM, Yahr MD. Parkinsonism:onset, progression and mortality. 1967. Neurology,2001,57(10 Suppl 3): S11-26
4.KitamuraY,Shimohama S,Akaike A,et al.The parkinsonian models: invertebrates to mammals. Jpn J Phannacol, 2000, 84 (3):237-243
5.Luquin MR. Experimental models of Parkinson disease. Rev Neurol, 2000, 31 (1):60-66
6.Marti M,Rodi D,Li Q,et al. Nociceptin/orphanin FQ receploT agonists allenuate L-DOPA-induced dyskinesias. J Neurosci,2012,32(46): 16106-16119
7.Meissner W, Hill MP, Tison F, et al. Neuroprotective strategies for Parkinson's disease: Conceptual limits of animal models and clinical trials. Trends Pharmacol Sci, 2004, 25 (5):249-253
8.Mokry J. Experimental models and behavioural tests used in the study of Parkinson's disease. Physiol Res,1995, 44 (3):143-150
9.Parkinson J. An essay on the shaking palsy. London: herwwod, Nelly and Jones, 1817
10.Tolwani RJ, Jakowec MW, Petzinger GM, et al. Experimental models of Parkinson's disease: insights from many models. Lab Anim Sci, 1999,49 (4):363-371